Member Info for Bankfool

Jenny, I think you have got it spot on. The charts are informative, but it takes real skil to interpret them in a volitile market and they only hint at a possible future at best.
Personally I am more concerned if VAL offers quality. If the quality is there then there is reason to think we will get a return on investment over time as the mcap increases.
Nothing wrong with wanting to derisk either. There is the opportunity cost to consider as well after all. Talking of which I put my proceeds from selling half my VAL shares into BOO. I thought they had cleaned up thier act and then the sp dropped yesterday and people were posting links to stories about boohoo's alliedged links to money laundering! Oh well lol.
As for me I am keeping an eye on things this week. I think we are pretty much at bottom. The only thing that concerns me is the sp falling below the 50 day moving average as this would indicate furher downward movement is possible. I am very close to topping up though.

Oh brilliant, so I put money in after boo cleans up its act and then this.
Thankfully its just alligations at the moment and hopefully this is nothing.

Comparing SAR and VAL can result in the check out fallicy, i.e. the other queue is moving faster. The fact is that the ponit of putting money into a small cap businesses is that there is scope to grow the business and this results in the increase in sp we are all looking for.
The big issue is whether the investment is an investment in quality. For years there was little to go on other than George's assertion that "it works". However since regime change we have reason to think that there is genuine quality in VAL, first there has been a number of TR1 shareholders, something that was simply impossible under the old regime. TR1 shareholders are not the sort to just throw tonnes of money at a company for no reason. There are also the interim results that are generally favorable. Lastly we are lucky enough to have posters on here who can give sensible evaluation of VAL products and study results. By all means consider putting money into the bio tech (s) of your choice, but if the company has quality, the longer you hold the more you can gain.

Not sure why there is such a marked difference in market cap, but as cancer treatments are such complex area I don't think it is a matter of having to choose a company as the one company that's going to cure cancer. I am in both Val and sclp. If people are interested in cancer focused biotechs there is no harm in investing in a few, just do your research first. The only other thing I would suggest is be careful about the weighting of cancer focused biotech in a portfolio. As we are all aware these can be very volitile shares so any investor should be careful to manage the risk of being exposed to that level of volitlity.

I use the 20, 50 and 200 day MAs as well.
At the begining of the year I was posting that the sp had been below the 200 day MA for petty much 100% of the time i.e. there was a stomg downward trend and I used this along with other arguments to militate for regime change. It was great that Freddie and ValJu were able to effect that regime change.
After regime change the sp started to rise, but I argued that there was still a lot of risk as we hadn't even been able to maintain a sp level for 20 days.
My use of the 20 and 200 day MAs helped me prevent taking unnecessary risks, however others who had averaged down in 2019 or brought in at the 3.5 to 7p (i.e. taking a risk I would not take) had brought shares at levels that would have resulted in fantastic gains.
I also keep an eye on the candlestick length. The longer the greater the buying or selling pressure. I used this a couple of years ago when I made a nice % gain on sclp. The price was going up but the candlestick bodies were getting shorter. On the Friday the candlestick body was short, I sold and I made a profit and I thought I had done well. When Monday came the price shot up furher and the candlestick body was longer again. (wick length is also interesting, it's an element that makes dragonfly and gravestone doji interesting).
The ponit is that graphical analysis is a useful tool and can be very helpful to help manage risks and help people walk away with profits rather than losses, but they do not predict the future. Of course those better versed in their use might have more profit than me under the same circumstances. I would recommend googling candlestick analysis, even a simple google search comes back with informative results. Looking forward to a good day today.

Knuttie, I am here to make money.
Why are you so twitchy about someone who takes ethical issues seriously?
You are the type of invester who puts me off.
Don't worry though, I won't be posting often I am interested in gains not opinions.

I brought into boo last week. The ethics of boohoo have been an issue for me. When I last scandal broke I was considering buying in because there were plenty on here saying it was old news and once the review was done I wasn't so opposed to buying into boohoo. I think it is fair to say that the rag trade is one presents a ethical risk because of the cost drivers and complex supply chains. Boohoo is certainly not the first fashion/clothing company to get caught out this way. However beyond that I have found certain posters on here off putting because they are willing to be complicit and turn a blind eye to ethical issues when their share price is compromised. I wouldn't want to associated with people who have such convenient views. I appreciate this could continue to rear its head again, but the proper responce is militate for better standards, not to turn a blind eye.

I am really pleased to read Iceman's post. More than just giving an view Iceman provided details of the indicators used so anyone can go and check themselves. Much kudos to Iceman for putting thier neck out like that.
Just a couple of things, I don't recognise Friday's candle stick as a dragonfly doji and it is important to recongosise that it is the candlestick pattern following a dragonfly doji that informs the subsequent trend.
That said Iceman has put forward an excellent analysis and I will be watching VAL with much interest on Monday. I don't really have the funds till payday now to buy more VAL and there is a genuine risk I might miss out. Here's hopping to a good Monday, (I still have half my stake in VAL after all) and if its good I will be attempting to scrap together funds to top up next week if I can. Gla.

I brought into dge before covid, I was looking for a good performer which paid a good div. I have the funds to top up and dge is at a more attractive price (from when I brought in) but although the sp has been recovering the announcement of hospitality focused lock downs are making me think twice. Does anyone have a perspective on this isssue? Is it likely that new restrictions will cause a dip?

Well like I said earlier Baxsterssoup we haven't fallen through 20p this week and if we stay above that level next week I will be calling bottom and will be putting aside funds for a top up.
Without any details of what indicators Majorboy used I find thier prediction unconvincing.

Majorboy I can understand that a chart might indicate a downward trend, but predictions of turnaround, how have you concluded that? The sp is currently below the 20 day MA and above the 50 day MA. If the sp continued below the 50 day MA then I might agree it will go furher down, but just don't understand what indicators you are using to make your prediction of an eventual upturn?

Definately the expression of the day!
I hope you are right though the % movements swings on a daily basis have been alittle alarming but let's face it we are not falling through 20p and if we don't fall through it next week I will be calling bottom.
I would say this is a good opportunity to top up. I will certainly be thinking seriously about topping up after pay day.
I might not get the same price between now and 1/11/20 and I might not be lucky enough to get in at the bottom, but I am genuinely optimistic about future sp levels

Nelson, very interesting thanks. I was attracted to banks as they were safe and had a bit of volitility. I have traded tranches of Lloy and leveraged profits, its just been a case that the unexpected has happened on occasion and I have been holding when I should have sold. I think I am a little deflated as every other company I look at has had a v shaped recovery, but bank shares have not. Looking at Lloy and I wonder if they will ever get back to 60p? With the dividend cut they are even less attractive. Technically they could be a good buy as the dividend yeild when divs resumed will be brilliant on shares brought now, but who knows? I think in the next few months I will add to my gsk, Hl., dge pots depending on performance and get the divs from them. Think I will keep something back for Val as well as we get nearer to the next update.

I put some money into gsk 1 hour before they announced thier financial results and took an immediate hit . I am currently 25% down. Poor bankfool, always getting in with the wrong crowd lol

Hi Grace, up late, or are you trying to rival my early starts?! I think the rapid jumping in and out of AIM stocks is a result of many holders not really being investors. A proper investor sees the potential and understands what the company does to make long term investment choices and get higher long term gains, the trader on the other hand is only looking to turn a profit and get out before they get burnt. AIM attracts traders like fly paper. I have been looking at my performance over the years the amount of money pumped into NWG and LLOY, 60% down on NWG and the dividend cut. perhaps I am just no good at investing or trading. Its 6:45 and I ready feel depressed lol

Lol

Hi Lucky, it was a good question to ask, but I wouldn't hold my breath waiting for a JV to be announced.
If valirx have been in talks for 5 years it seems unlikely that suzy will land a deal anytime soon. It was rather gracious of suzy to take responsibility though. If talks have been ongoing for 5 years the work done so far in getting a JV very much falls under the old regime.
The other thing is that it might be possible to land a deal on partial results, the fact that valirx hasn't achieved that in 5 years makes much more likely that chances of success will only be meaningfully increased upon publication of the full results.
Fingers crossed that valirx can agree a JV, but I am inclined to think that we are entering into a quitier period and we should just sit back and wait, consider our positions and top up in line with those positions whilst we wait for the next bit of meaningful news.

Excellent advice snowwoman, recommended!

I brought in to boo today. I had some profits to leverage from a sell elsewhere. I thought sub 350 would be good, got in at 342 thinking I had done well! But as a wise man once said, the value of your investment can down down as well as down!
Hopefully things will start moving back up tomorrow :)

In a word no. It would be perfectly legit to publish a report under the circumstances.
I took a kicking on quindell when Gotham City research published a report.
The issue got to court, Gotham City research didn't turn up to defend accusations and quindell won by default. (things went really wrong from there. Quindell is now Watchstone Group)